• SPX
  • $5,893.62
  • 0.39 %
  • $23.00
  • DJI
  • $43,389.60
  • -0.13 %
  • -$55.39
  • N225
  • $38,429.37
  • 0.55 %
  • $208.52
  • FTSE
  • $8,109.32
  • 0.57 %
  • $45.71
  • IXIC
  • $18,791.81
  • 0.6 %
  • $111.69
Innoviva, Inc. (INVA) Stock Price, News & Analysis

Innoviva, Inc. (INVA) Stock Price, News & Analysis

Currency in USD Disclaimer

$18.94

$0.04

(0.21%)

Day's range
$18.86
Day's range
$19.19
50-day range
$18.4
Day's range
$21.28
  • Country: US
  • ISIN: US45781M1018
52 wk range
$13.41
Day's range
$21.28
  • CEO: Mr. Pavel Raifeld C.F.A.
  • Website: Visit Site


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 1.88
  • Piotroski Score 8.00
  • Grade Buy
  • Symbol (INVA)
  • Company Innoviva, Inc.
  • Price $18.94
  • Changes Percentage (0.21%)
  • Change $0.04
  • Day Low $18.86
  • Day High $19.19
  • Year High $21.28

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA, and VI; and TRELEGY ELLIPTA, a once-daily combination medicine consisting of an ICS, LAMA, and LABA. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. The company has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.

  • Last Earnings 07/30/2015
  • Ex-Dividend for 5/16 Dividend 09/08/2015
  • Dividend Payable 09/30/2015
  • Today N/A
  • Next Earnings (Estimated) 02/05/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $13.00
  • High Stock Price Target $13.00
  • Low Stock Price Target $13.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $2.24
  • Trailing P/E Ratio 7.21
  • Forward P/E Ratio 7.21
  • P/E Growth 7.21
  • Net Income $179.72 M

Income Statement

Quarterly

Annual

Latest News of INVA

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Innoviva, Inc. Frequently Asked Questions

  • What is the Innoviva, Inc. stock price today?

    Today's price of Innoviva, Inc. is $18.94 — it has increased by +0.21% in the past 24 hours. Watch Innoviva, Inc. stock price performance more closely on the chart.

  • Does Innoviva, Inc. release reports?

    Yes, you can track Innoviva, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Innoviva, Inc. stock forecast?

    Watch the Innoviva, Inc. chart and read a more detailed Innoviva, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Innoviva, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Innoviva, Inc. stock ticker.

  • How to buy Innoviva, Inc. stocks?

    Like other stocks, INVA shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Innoviva, Inc.'s EBITDA?

    Innoviva, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Innoviva, Inc.’s financial statements.

  • What is the Innoviva, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0.5788837961, which equates to approximately 57.89%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Innoviva, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Innoviva, Inc.'s financials relevant news, and technical analysis. Innoviva, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Innoviva, Inc. stock currently indicates a “sell” signal. For more insights, review Innoviva, Inc.’s technical analysis.

  • A revenue figure for Innoviva, Inc. for its last quarter?

    Innoviva, Inc. published it's last quarterly revenues at $89.51 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.